Medication Abortion in Jeopardy?
Gender Justice Legal Director Jess Braverman and Executive Director Megan Peterson discuss the Alliance Defending Freedom’s lawsuit against the FDA for its approval of Mifepristone over 20 years ago.
Mifepristone is the first pill in the two-pill regimen that makes up medication abortion. If successful, the lawsuit could hinder access to medication abortion across the country. The Gender Justice team discusses how this ruling would affect Minnesota providers and patients, as well as new updates on reproductive freedom legislation advancing at the Minnesota legislature this session.
About The Gender Justice Brief
The Gender Justice Brief is produced by Gunther Michael Jahnl of IQONEQ Communications Solutions and Audra Grigus.
Visit Gender Justice and UnRestrict Minnesota.
Latest Episodes
- SCOTUS Chat: The Future of Medication Abortion Access
- Preconceived: Exposing Crisis Pregnancy Centers
- Another Victory for Abortion Rights in Minnesota
- Gender Equity in Minnesota: 2024 Legislative Agenda Briefing
- Exposing Fake Clinics: Minnesota’s “Crisis Pregnancy Centers”
- Equality for All: Minnesota’s Equal Rights Amendment
- Roe v. Wade’s Reversal: Impact in the Heartland
- Learning from the Green Wave: Fighting for Abortion Access in Latin America
- End of Year Mail Bag: Erin & Jess answer your questions
- Ali v. Sun Country: Justice for a Nursing Mom